RE:RE:RE:RE:New info out Also, I think the R+F contract is delayed due to 0.4% trials. I no longer believe mgmt BS in Dec 2019 NR. Recall Obagi cancelled its contract when Sirona went and produced a better version of the skin ligthener.
Dec 2, 2019 - "The planned clinical trial is anticipated to be a value-add for the compound. Current licenses and ongoing product development by partners for TFC-1067 will not be delayed by the studies."
lscfa wrote: Can't trust mgmt. When the 0.2% results came out mgmt did not mention that 1067 failed to lighten skin other than dark spots. Shareholders found out about this much later when the study was finally published for all to see.
wexworth wrote:
it says the 0.4% trial is nearing completion. Am I missing something here because you can take any biotech on the planet, and when they release positive clinical results (to be determined in this case), their share prices go up, and depending upon the nature of the results, goes way up. You are certainly welcome to your widget factory comparison.